Editor Profile

editor profile image is not found.

Dr. Giuseppe Murdaca, M.D., Ph.D.

Associate Professor

2017 - Present

Di.M.I.-University of Genova

Genova

Italy

editor profile QR Code is not found.
No content available to display!!!
  • Immunodeficiency
  • Autoimmunity
  • Neuro-endocrino-immunology
  • Pharmacogenomics
  • Vaccine and Autoimmune Diseases
  • Murdaca G., Banchero S., Casciaro M., Paladin F., Tafuro M., Monacelli F., Nencioni A., Bruschetta R., Pioggia G., Tartartarisco G., Gangemi S. Multiparametric evaluation of geriatric patients admitted to intermediate care: impact on geriatric rehabilitation. Diagnostics 2023 in press. (IF: 3.6).
  • Deibel E, Carreira PE, Vonk M, Del Papa N, Bečvář R, Guillén-Del-Castillo A, Campochiaro C, Poormoghim H, Liem S, Lazzaroni MG, Giollo A, Mekinian A, de Vries-Bouwstra J, De Santis M, Balbir-Gurman A, Mihai C, De Luca G, Moiseev S, Zanatta E, Foti R, Rednic S, Denton C, Cutolo M, Belloli L, Airo P, Garzanova L, Moroncini G, İnanç M, Panopoulos S, Tandaipan JL, Chatelus E, Rosato E, Kuwana M, Yavuz S, Alegre-Sancho JJ, Smith V, Szűcs G, Henes J, Rodríguez-Pintó I, Atzeni F, Spierings J, Truchetet ME, Milchert M, Brito de Araujo D, Riemekasten G, Bernardino V, Martin T, Del Galdo F, Vacca A, Mendoza F, Midtvedt Ø, Murdaca G, Santiago T, Codullo V, Cacciapaglia F, Walker U, Brunborg C, Tirelli F, Allanore Y, Furst DE, Matucci M, Gabrielli A, Distler O, Hoffmann-Vold AM. Does the impact of COVID-19 on patients with systemic sclerosis change over time? Arthritis Care Res (Hoboken). 2023 in press. (IF: 5.178).
  • Murdaca G., Paladin F., Martino G., Gangemi S. Impact of Immunosenescence on Viral Infections with an Emphasis on COVID-19. Front. Biosci. (Landmark Ed)  2023 in press. (IF: 3.1).
  • Palumbo A, Atzeni F, Murdaca G, Gangemi S. The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33. Int J Mol Sci. 2023;24(15):12143. (IF: 5.6).
  • Caserta S., Gangemi S., Murdaca G., Allegra A. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. Int J Mol Sci. 2023;24(14):11544. (IF: 5.6).
  • Ursini F, Ruscitti P, Addimanda O, Foti R, Raimondo V, Murdaca G, Caira V, Pigatto E, Cuomo G, Lo Gullo A, Cavazzana I, Campochiaro C, Naclerio C, De Angelis R, Ciaffi J, Mancarella L, Brusi V, Marchetti E, Motta F, Visentini M, Lorusso S, De Santis M, De Luca G, Massaro L, Olivo D, Pellegrini R, Francioso F, Luppino J, Di Cola I, Foti R, Varcasia G, Caso F, Reta M, Dagna L, Selmi C, Iagnocco A, Giacomelli R, Iannone F, Ferri C. Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group. RMD Open. 2023;9(2):e003022. (IF: 5.806).
  • Murdaca G., Gangemi S., Greco M. The IL-33/IL-31 Axis in Allergic and Immune-Mediated Diseases. Int J Mol Sci. 2023;24(11):9227. (IF: 6.208).
  • Allegra A., Murdaca G., Mirabile G., Gangemi S. Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. Biomedicines 2023;11(5):1325. (IF: 4.757).
  • Brancaccio R., Murdaca G., Casella R., Loverre L., Bonzano L., Nettis E., Gangemi S. miRNAs’ Cross-Involvement in Skin Allergies: A New Horizon for the Pathogenesis, Diagnosis and Therapy of Atopic Dermatitis, Allergic Contact Dermatitis and Chronic Spontaneous Urticaria. Biomedicines 2023;11(5):1266. (IF: 4.757).
  • Murdaca G., Paladin F., Mangini G., Tiso D., Gangemi S. TBC and COVID: an interplay between two infections. Expert Opin Drug Saf 2023;22(4):303-311. (IF: 4.011).
  • De Angelis R, Ferri C, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano AM, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Pellagrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Guiducci S, Doria A, Salvarani C, Iannone F, Matucci-Cerinic M; SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology. RMD Open 2023;9(1):e002890. (IF: 5.806).
  • Furci F., Murdaca G., Pelaia C., Imbalzano E., Pelaia G., Caminati M., Allegra A., Senna G., Gangemi S. TSLP and HMGB1: inflammatory targets and potential biomarkers for precision medicine in asthma and COPD. Biomedicines 2023;11(2):437. (IF: 4.757).
  • Murdaca G., Paladin F., Borro M., Ricciardi L., Gangemi S. Prevalence of Autoimmune and Autoinflammatory Diseases in Chronic Urticaria: Pathogenetic, Diagnostic and Therapeutic Implications. Biomedicines 2023;11(2):410. (IF: 4.757).
  • Allegra A., Murdaca G., Gammeri L., Ettari R., Gangemi S. Alarmins and MicroRNAs, a New Axis in the Genesis of Respiratory Diseases: Possible Therapeutic Implications. Int J Mol Sci. 2023;24(2):1783. (IF: 6.208).
  • Cabanillas B., Murdaca G., Guemari A., Torres MJ., Azkur AK., Aksoy E., Vitte J., de las Vecillas L., Mattia Giovannini M., Fernández-Santamaria R, Castagnoli R., Orsi A., Amato R., Giberti I., Català A., Ambrozej D., Schaub B., Tramper-Stranders GA., Novak N., Nadeau KC., Ioana Agache I., Akdis M., Akdis CA. A compilation answering 50 questions on Monkeypox virus and the current Monkeypox outbreak. Allergy 2023;78(3):639-662. (IF: 14.710).
  • Imbalzano E., Murdaca G., Lana Orlando L., Gigliotti De fazio M., Terranova D., Tonacci A., Gangemi S. Alarmins as a possible target of future therapies for atrial fibrillation. Int J Mol Sci. 2022;23(24):15946. (IF: 6.208).
  • Murdaca G., Gangemi S. Vitamin D in Health and Disease. Biomedicines 2022;11(1):10. (IF: 4.757).
  • Furci F., Murdaca G., Allegra A., Gammeri L., Senna G., Gangemi S. IL-33 and the cytokine storm in COVID-19: from a potential immunological relationship towards precision medicine. Int J Mol Sci. 2022;23(23):14532. (IF: 6.208).
  • Murdaca G, Banchero S, Casciaro M, Tonacci A, Billeci L, Nencioni A, Pioggia G, Genovese S, Monacelli F, Gangemi S. Potential predictors for cognitive decline in vascular dementia: a machine learning analysis. Processes 2022 in press. (IF: 3.352).
  • Murdaca G, Paladin F, Casciaro M, Vicario CM, Gangemi S, Martino G. Neuro Inflammaging and Psychopatological Distress. Biomedicines 2022;10(9):2133. (IF: 4.757).
  • Murdaca G, Allegra A, Tonacci A, Musolino C, Ricciardi L, Gangemi S. Mast Cells and Vitamin D Status: A Clinical and biological link in the onset of allergy and bone diseases. Biomedicines 2022;10(8):1877.  (IF: 4.757).
  • Ferri C, De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Guiducci S, Girelli F, Riccieri V, Zanatta E, Bosello S, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Masini F, Gigante A, Bellando-Randone S, Pellegrino G, Pigatto E, Lazzaroni M, Franceschini F, Generali E, Mennillo G, Barsotti S, Pagano Mariano G, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D’Angelo S, Cozzi F, Doria A, Iannone F, Salvarani C, Matucci-Cerinic M, On behalf of SPRING-SIR (Systemic Sclerosis PRogression INvestiGation group of the Italian Society of Rheumatology). Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. Autoimmun Rev 2022;21(10):103159. (IF: 17.39).
  • Murdaca G, Paladin F, Tonacci A, Borro M, Greco M, Gerosa A, Isola I, Allegra A, Gangemi S. Involvement of Il-33 in the pathogenesis and prognosis of major respiratory viral infections: future perspectives for personalized therapy. Biomedicines. 2022;10(3):715.  (IF: 4.757).
  • Murdaca G, Noberasco G, Olobardi D, Ogliastro M, Sibilio R, Sambuceti G, Balzano R, Sticchi L, Icardi G, Orsi A. Systemic sclerosis and vaccinations: a three-year register-based cohort study about vaccination rate and uptake from Liguria referral center, northwest Italy. Hum Vaccin Immunother. 2022;18(1):2025732. (IF: 3.452).
  • De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Guiducci S, Girelli F, Riccieri V, Zanatta E, Bosello S, Cavazzana I, Ingegnoli F, Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Masini F, Gigante A, Bellando-Randone S, Pellegrino G, Pigatto E, Dall'Ara F, Lazzaroni MG, Generali E, Mennillo G, Barsotti S, Mariano GP, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Risa AM, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Doria A, Iannone F, Salvarani C, Matucci-Cerinic M, Ferri C; Systemic sclerosis PRogression INvestiGation group (SPRING). Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology. J Rheumatol. 2022;49(2):176-185. (IF: 4.666).
  • Negrini S, Contini P, Murdaca G, Puppo F. HLA-G in Allergy: Does It Play an Immunoregulatory Role? Front Immunol. 2022;12: 789684. (IF: 7.561).
  • Ferri C, Raimondo V, Gragnani L, Giuggioli D, Dagna L, Tavoni A, Ursini F, L'Andolina M, Caso F, Ruscitti P, Caminiti M, Foti R, Riccieri V, Guiducci S, Pellegrini R, Zanatta E, Varcasia G, Olivo D, Gigliotti P, Cuomo G, Murdaca G, Cecchetti R, De Angelis R, Romeo N, Ingegnoli F, Cozzi F, Codullo V, Cavazzana I, Colaci M, Abignano G, De Santis M, Lubrano E, Fusaro E, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Bosco YD, Amato G, Giannini D, Bilia S, Masini F, Pellegrino G, Pigatto E, Generali E, Mariano GP, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Ferrari T, Campochiaro C, Brusi V, Fredi M, Moschetti L, Cacciapaglia F, Paparo SR, Ragusa F, Mazzi V, Elia G, Ferrari SM, Di Cola I, Vadacca M, Lorusso S, Monti M, Lorini S, Aprile ML, Tasso M, Miccoli M, Bosello S, D'Angelo S, Doria A, Franceschini F, Meliconi R, Matucci-Cerinic M, Iannone F, Giacomelli R, Salvarani C, Zignego AL, Fallahi P, Antonelli A. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies. Curr Pharm Des. 2022;28(24):2022-2028. (IF: 3.310).
  • Murdaca G, Noberasco G, Olobardi D, Lunardi C, Maule M, Delfino L, Triggiani M, Cardamone C, Benfaremo D, Moroncini G, Vacca A, Susca N, Gangemi S, Quattrocchi P, Sticchi L, Icardi G, Orsi A. Current Take on Systemic Sclerosis Patients' Vaccination Recommendations. Vaccines (Basel). 2021;9(12):1426. (IF: 4.422).
  • Ferri C, Giuggioli D, Raimondo V, L'Andolina M, Dagna L, Tavoni A, Caso F, Ursini F, Piero R, Caminiti M, Foti R, Riccieri V, Guiducci S, Pellegrini R, Zanatta E, Varcasia G, Olivo D, Gigliotti P, Cuomo G, Murdaca G, Cecchetti R, De Angelis R, Romeo N, Ingegnoli F, Cozzi F, Codullo V, Cavazzana I, Colaci M, Abignano G, De Santis M, Lubrano E, Fusaro E, Rossa AD, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Dal Bosco Y, Amato G, Giannini D, Bilia S, Masini F, Pellegrino G, Pigatto E, Generali E, Mariano GP, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Caminiti R, Scorpiniti D, Ferrari T, Campochiaro C, Brusi V, Fredi M, Moschetti L, Cacciapaglia F, Gragnani L, Monti M, Lorini S, Paparo SR, Ragusa F, Mazzi V, Elia G, Ferrari SM, Di Cola I, Vadacca M, Lorusso S, Barsotti S, Aprile ML, Marco T, Miccoli M, Bosello S, Matucci-Cerinic M, D'Angelo S, Doria A, Franceschini F, Meliconi R, Iannone F, Giacomelli R, Zignego AL, Varcasia P, Antonelli A. Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. Curr Pharm Des. 2021;27(41):4245-4252. (IF: 3.310).
  • Rosamilia F, Noberasco G, Olobardi D, Orsi A, Icardi G, Lantieri F, Murdaca G. Flu and Pneumococcal Vaccine Coverage in Scleroderma Patients still need to be prompted: a Systematic Review. Vaccines (Basel). 2021 Nov 15;9(11):1330. (IF: 4.422).
  • Murdaca G, Paladin F, Tonacci A, Isola S, Allegra A, Gangemi S. The Potential Role of Cytokine Storm Pathway in the Clinical Course of Viral Respiratory Pandemic. Biomedicines. 2021;9(11):1688. (IF: 4.757).
  • Murdaca G, Di Gioacchino M, Greco M, Borro M, Paladin F, Petrarca C, Gangemi S. Basophils and Mast Cells in COVID-19 Pathogenesis. Cells. 2021;10(10):2754. (IF: 6.600).
  • Murdaca G, Caprioli S, Tonacci A, Billeci L, Greco M, Negrini S, Cittadini G, Zentilin P, Ventura Spagnolo E, Gangemi S. A Machine Learning Application to Predict Early Lung Involvement in Scleroderma: A Feasibility Evaluation. Diagnostics (Basel). 2021;11(10):1880. (IF: 3.706).
  • Murdaca G, Allegra A, Paladin F, Calapai F, Musolino C, Gangemi S. Involvement of alarmins in the pathogenesis and progression of multiple myeloma. Int J Mol Sci. 2021;22(16):9039. (IF: 5.923).
  • Angeletti A, Bruschi M, Moroni G, Sinico R, Franceschini F, Fredi M,; Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez G, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d’Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco CM, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina EE, Ravelli A, Ghiggeri GM. Second wave antibodies in autoimmune renal diseases: the case of lupus nephritis. J Am Soc Nephrol. 2021;32(12):3020–3. (IF: 10.121).
  • Murdaca G, Paladin F, Gangemi S. Role of Vitamin D in the Clinical Course of Nasal Polyposis. Biomedicines 2021;9(8):855. (IF: 4.757).
  • Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Mosca M, Tincani A, Candiano G, Prunotto M, Volpi S, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis. Rheumatology (Oxford). 2021;60(7):3176-3188. (IF: 7.580).
  • Bruschi M, Moroni G, Sinico RA, Franceschini F, Fredi M, Vaglio A, Cavagna L, Petretto A, Pratesi F, Migliorini P, Locatelli F, Pazzola G, Pesce G, Bagnasco M, Manfredi A, Ramirez GA, Esposito P, Murdaca G, Negrini S, Cipriani L, Trezzi B, Emmi G, Cavazzana I, Binda V, d'Alessandro M, Fenaroli P, Pisani I, Garibotto G, Montecucco C, Santoro D, Scolari F, Volpi S, Mosca M, Tincani A, Candiano G, Prunotto M, Verrina E, Angeletti A, Ravelli A, Ghiggeri GM. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study. Rheumatology (Oxford). 2021;60(7):3388-3397. (IF: 7.580).
  • Carbone RG, Negrini S, Murdaca G, Puppo F. Stem Cell Therapy for the Treatment of Chronic Ischemic Heart Disease. Cardiol Cardiovasc Med 2021; 5 (3): 277-284. (IF: 3.500).
  • Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, Indiveri F, Puppo F. Sjögren's syndrome: a systemic autoimmune disease. Clin Exp Med. 2022;22(1):9-25. (IF: 3.984).
  • Murdaca G, Banchero S, Tonacci A, Nencioni A, Monacelli F, Gangemi S. Vitamin D and Folate as Predictors of MMSE in Alzheimer's Disease: A Machine Learning Analysis. Diagnostics (Basel). 2021;11(6):940. (IF: 3.706).
  • Murdaca G, Greco M, Borro M, Gangemi S. Hygiene hypothesis and autoimmune diseases: A narrative review of clinical evidences and mechanisms. Autoimmun Rev. 2021;20(7):102845. (IF: 9.754).
  • Murdaca G, Gerosa A, Paladin F, Petrocchi L, Banchero S, Gangemi S. Vitamin D and Microbiota: Is There a Link with Allergies? Int J Mol Sci. 2021;22(8):4288. (IF: 5.923).
  • Borro M, Negrini S, Long A, Chinthrajah S, Murdaca G. H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far? Clin Mol Allergy. 2021;19(1):4.  (IF: 2.88).
  • Borro M, Murdaca G, Monachesi M, Negrini S. Unexpected adverse event of insulin therapy in diabetes mellitus. Acta Diabetol. 2021;58(6):813-815. (IF: 4.280).
  • Ferri C, Giuggioli D, Raimondo V, Dagna L, Riccieri V, Zanatta E, Guiducci S, Tavoni A, Foti R, Cuomo G, De Angelis R, Cozzi F, Murdaca G, Cavazzana I, Romeo N, Codullo V, Ingegnoli F, Pellegrini R, Varcasia G, Rossa AD, De Santis M, Abignano G, Colaci M, Caminiti M, L'Andolina M, Lubrano E, Spinella A, Lumetti F, De Luca G, Bellando-Randone S, Visalli E, Bilia S, Giannini D, Masini F, Pellegrino G, Pigatto E, Generali E, Dall'Ara F, Mariano GP, Barsotti S, Pettiti G, Zanframundo G, Brittelli R, Aiello V, Scorpiniti D, Ferrari T, Caminiti R, Campochiaro C, D'Angelo S, Iannone F, Matucci-Cerinic M, Doria A, Miccoli M, Fallahi P, Antonelli A; COVID-19 & Autoimmune Systemic Diseases Italian Study Group. COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study. Lancet Rheumatol. 2021;3(3):e166-e168. (IF: 8.136).
  • Cozzani E, Muracchioli A, Murdaca G, Beccalli M, Caprioli S, Zentilin P, Ameri P, Grosso M, Russo R, Carmisciano L, Parodi A. Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications. Front Immunol. 2021;12:588753. (IF: 7.561).
  • Murdaca G, Greco M, Negrini S, Casciaro M, Gangemi S. The Role of Skin and Gut Microbiome and Epigenetic Modifications in Skin-Autoimmune Disorders. Curr Mol Med. 2021;21(4):283-290. (IF: 2.254).
  • Murdaca G, Pioggia G, Negrini S. Vitamin D and Covid-19: an update on evidence and potential therapeutic implications. Clin Mol Allergy. 2020;18(1):23. (IF: 2.88).
  • Boutros A, Schiavi C, Cecchi F, Spagnolo F, Tanda ET, Giusti F, Murdaca G, Queirolo P. A case of immune-related toxicity during adjuvant treatment with BRAF plus MEK inhibitors. Front Immunol. 2020;11:579523. (IF: 5.085).
  • Borro M, Murdaca G, Greco M, Negrini S, Setti M. A rare hepatic mass in an italian resident. BMC Gastroenterol. 2020;20(1):295. (IF: 2.489).
  • Ferri C, Giuggioli D, Raimondo V, L’Andolina M, Tavoni A, Cecchetti R, Guiducci S, Ursini F, Caminiti M, Varcasia G, Gigliotti P, Pellegrini R, Olivo D, Colaci M, Murdaca G, Brittelli R, Pagano Mariano G, Amelia Spinella A, Bellando-Randone S, Aiello V, Bilia S, Giannini D, Ferrari T, Caminiti R, Brusi V, Meliconi R, Fallahi P, Antonelli A for the COVID-19 & ASD Italian Study Group. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020;39(11):3195-3204. (IF: 2.394).
  • Murdaca G, Greco M, Vassallo C, Gangemi S. Tranexamic acid adverse reactions: a brief summary for internists and emergency doctors. Clin Mol Allergy 2020;18:16. . (IF: 2.88).
  • Russo R, Cozzani E, Murdaca G, dePasquale R, Parodi A. Spontaneous Ecchymotic Lesions with Systemic Symptoms: A Quiz. Acta Derm Venereol. 2020;100(15):adv00246. (IF: 2.88).
  • Contini P, Murdaca G, Puppo F, Negrini S. HLA-G Expressing Immune Cells in Immune Mediated Diseases. Front Immunol. 2020;11:1613. (IF: 4.716).
  • Murdaca G, Noberasco G, Battaglini A, Vassallo C, Giusti F, Greco M, Schiavi C, Sticchi L, Icardi G, Orsi A. Systemic sclerosis and vaccinations: a register-based cohort study about seasonal influenza and S. Pneumoniae vaccination rate and uptake from Liguria regional center, northwest Italy. Vaccines 2020;8(2):204. (IF: 4.760).
  • Ferri C, Giuggioli D, Guiducci S, Lumetti F, Bajocchi G, Magnani L, Codullo V, Ariani A, Girelli F, Riccieri V, Pellegrino G, Bosello S, Foti R, Visalli E, Amato G, Benenati A, Cuomo G, Iannone F, Cacciapaglia F, Da Angelis R, Ingegnoli F, Talotta R, Campochiaro C, Dagna L, De Luca G, Bellando-Randone S, Spinella A, Murdaca G, Romeo N, De Santis M, Generali E, Barsotti S, Della Rossa A, Cavazzana I, Dall'Ara F, Lazzaroni MG, Cozzi F, Doria A, Pigatto E, Zanatta E, Ciano G, Beretta L, Abignano G, D'Angelo S, Mennillo G, Bagnato G, Calabrese F, Caminiti M, Pagano Mariano G, Battaglia E, Lubrano E, Zanframundo G, Iuliano A, Furini F, Zanetti A, Carrara G, Rumi F, Scirè CA, Matucci-Cerinic M; Italian Society of Rheumatology (SIR). Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum. Clin Exp Rheumatol. 2020;38 Suppl 125(3):40-47.  (IF: 3.238).
  • Ricciardi E, La Malfa G, Guglielmi G, Cenni E, Micali M, Corsello LM, Lopena P, Manco L, Pontremoli R, Moscatelli P, Murdaca G, Musso N, Montecucco F, Ameri P, Porto I, Pende A, Canepa M. Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study. Intern Emerg Med. 2020;15(7):1219-1229. (IF: 2.335).
  • Carbone RG, Murdaca G, Negrini S, Penna D, Puppo F. Diagnosis of an unusual case of idiopathic mediastinal fibrosis by 18F-FDG PET/CT. Radiology Case Reports 2020;15(4):435-6. (IF: 0.430).
  • Negrini S, Contini P, Pupo F, Greco M, Murdaca G, Puppo F. Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus. Hum Immunol. 2019;81(4):162-167. (IF: 2.202).
  • Murdaca G, Greco M, Tonacci A, Negrini S, Borro M, Puppo F, Gangemi S. IL-33/IL-31 Axis in Immune-Mediated and Allergic Diseases. Int J Mol Sci. 2019;20(23): 5856. (IF: 4.183).
  • Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S. Effects of AntagomiRs on Different Lung Diseases in Human, Cellular, and Animal Models. Int J Mol Sci. 2019;20(16): E3938. (IF: 4.183).
  • Greco M., Negrini S., Schiavi C., Giusti F., Borro M., Puppo F., Murdaca G. Genetic factors and psoriatic arthritis. Open J Rheumatol Autoimmune Dis 2019;9(3):111-20. (IF: 0.21).
  • Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F, Gangemi S. Emerging role of vitamin D in autoimmune diseases: an update on evidence and therapeutic implications. Autoimmun Rev 2019;18(9):102350. (IF: 8.745).
  • Negrini S, Magnani O, Matucci-Cerinic M, Carignola R, Data V, Montabone E, Santaniello A, Adorni G, Murdaca G, Puppo F, Indiveri F, Della Rossa A, D’Ascanio A, Barsotti S, Giuggioli D, Ferri C, Lumetti F, Bosello SL, Canestrari G, Bellando Randone S, Bruni C, Guiducci S, Battaglia E, De Andres MI, Russo AA, Beretta L. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study. Clin Exp Med 2019;19(3):357-366. (IF: 2.787).
  • Murdaca G, Negrini S, Greco M, Schiavi C, Giusti F, Borro M, Puppo F. Immunogenicity of infliximab and adalimumab. Expert Opin Drug Saf. 2019;18(5):343-5. (IF: 3.156).
  • Butera F, Schenone S, Grammatico F, Tisa V, Barisione G, Guarona G, Bruzzone B, Murdaca G, Setti M, Orsi A. Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: an uncommon clinical presentation in a non-seasonal period. J Prev Med Hyg 2019; 60(1): E1-E4.
  • Negrini S, Murdaca G, Ferone D, Borro M. Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse. Thérapie 2019;74(5):547-9. (IF: 1.524).
  • Greco M, Negrini S, Schiavi C, Giusti F, Borro M, Vassallo C, Puppo F, Murdaca G. An uncommon presentation of pancreatic carcinoma. Am J Med 2019;132(6):e583-e584. (IF: 5.117).
  • Murdaca G, Negrini S, Pellecchio M, Greco M, Schiavi C, Giusti F, Puppo F. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opin Drug Saf. 2019;18(3):219-29. (IF: 3.156).
  • Murdaca G, Calamaro P, Lantieri F, Pigozzi S, Mastracci L, Grillo F, Magnani O, Ceppa P, Puppo F, Fiocca R. HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact. Virchows Arch. 2018;473(4):425-33. (IF: 2.936).
  • Contini P, Negrini S, Murdaca G, Borro M, Puppo F. Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis. Clin Exp Immunol. 2018;193(2):152-9. (IF: 3.542).
  • Zentilin P, Savarino V, Marabotto E, Murdaca G, Sulli A, Pizzorni C, Puppo F, Savarino E. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis. Semin Arthritis Rheum. 2018;47(4):569-74. (IF: 4.498).
  • Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Gulli R, Mandich P, Puppo F. Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis. Mod Rheumatol. 2018;28(3):417-431. (IF: 2.206).
  • Murdaca G, Negrini S, Magnani O, Penza E, Pellecchio M, Puppo F. Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis. Expert Opin Drug Saf. 2017;16(10):1173-9. (IF: 3.469).
  • Murdaca G, Lantieri F, Puppo F, Bezante GP, Balbi M. Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis. J Int Med Res. 2016;44(1 suppl):85-9. (IF: 1.431).
  • Contini P, Puppo F, Canonica GW, Murdaca G, Ciprandi G. Allergen-driven HLA-G expression and secretion in peripheral blood mononuclear cells from allergic rhinitis patients. Hum Immunol. 2016;77(12):1172-8. (IF: 2.127).
  • Murdaca G., Contini P., Negrini S., Ciprandi G., Puppo F. Immunoregulatory Role of HLA-G in Allergic Diseases. J Immunol Res. 2016;2016:6865758. (IF: 2.812).
  • Negrini S, Pappalardo F, Murdaca G, Indiveri F, Puppo F. The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med. 2017;17(3):257-67. (IF: 2.959).
  • Murdaca G., Contatore C., Gulli R., Mandich P., Puppo F. Genetic factors and Systemic Sclerosis. Autoimmun Rev 2016;15(5):427-32. (IF: 7.975).
  • Murdaca G., Orsi A., Spanò S., Puppo F., Durando P., Icardi G., Ansaldi F. Vaccine-preventable infections in Systemic Lupus Erythematosus. Hum Vaccin Immunother 2016;12(3):632-43. (IF: 2.366 ).
  • Murdaca G., Contini P., Cagnati P., Marenco S., Pieri G., Lantieri F., Picciotto A., Puppo F. Behavior of soluble HLA-A,-B,-C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy. Clin Exp Med. 2017;17(1):93-100. (IF: 2.959).
  • Murdaca G., Spanò F., Contatore M., Guastalla A., Penza E., Magnani O., Puppo F. Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety? Expert Opin Drug Saf 2016;15(1):43-52. (IF: 3.469).
  • Murdaca G., Russo R., Spanò F., Ferone D., Albertelli M., Schenone A., Contatore M., Guastalla A., De Bellis AM., Garibotto G., Puppo F. Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. Arch Endocrinol Metab 2015;59(6):554-8. (IF: 0.844).
  • Murdaca G., Spanò F., Contatore M., Guastalla A., Penza E., Magnani O., Puppo F. Infection risk associated with anti-TNF-α agents: a review. Expert Opin Drug Saf 14(4):571-82, 2015. (IF: 2.911).
  • Murdaca G, Gulli R, Spanò F, Mandich P, Puppo F. Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept? Drug Dev Res 75 Suppl 1:S7-S10, 2014. (IF: 0.734).
  • Gisondi P, Murdaca G. Seminars in research 2013: joint experiences using biologics in rheumatology and dermatology. Drug Dev Res 75 Suppl 1:S1-2, 2014. (IF: 0.734).
  • Murdaca G, Spanò F, Contatore M, Guastalla A, Magnani O, Puppo F. Pharmacogenetics of etanercept: role of TNF-a gene polymorphisms in improvement its efficacy. Expert Opin Drug Metab Toxicol 10(12):1703-10, 2014. (IF: 2.934).
  • Murdaca G, Spanò F, Contatore M, Guastalla A, Magnani O, Puppo F. Efficacy and  safety of etanercept in chronic immune-mediated disease. Expert Opin Drug Saf 13(5):649-61, 2014. (IF: 2.911).
  • Murdaca G, Gulli R, Spanò F, Lantieri F, Burlando M, Parodi A, Mandich P, Puppo F. TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis. J Invest Dermatol 134(10):2503-9, 2014. (IF: 6.372).
  • Murdaca G, Spanò F, Contatore M, Guastalla A, Puppo F. The potential use of TNF-α inhibitors in Systemic Sclerosis. Immunotherapy 6(3):283-9, 2014. (IF: 2.393).
  • Murdaca G, Spanò F, Puppo F. Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. Expert Opin Drug Saf 13(3):295-305, 2014. (IF: 2.911).
  • Murdaca G, Orsi A, Spanò F, Puppo F, Durando D, Icardi G, Ansaldi F. Influenza and pneumococcal vaccination of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev 13(2):75-84, 2014. (IF: 7.975).
  • Murdaca G, Spanò F, Puppo F. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis. Expert Opin Drug Saf 12(6):801-4, 2013. (IF: 2.621).
  • Murdaca G, Spanò F, Puppo F. Pharmacogenetics: reality or dream in predicting the response to TNF-α inhibitor treatment? J Genet Syndr Gene Ther 2013;S3: 007.
  • Murdaca G, Spanò F, Puppo F. Long term treatment of Rheumatoid Arthritis with Adalimumab. Open Access Rheumatology: Research and Reviews 5:43–9, 2013.
  • Boccardo F, Fulcheri E, Villa G, Molinari L, Campisi C, Dessalvi S, Murdaca G, Campisi C, Santi PL, Parodi A, Puppo F, Campisi C. Lymphatic Microsurgery to Treat Lymphedema: Techniques and Indications for Better Results. Ann Plast Surg 71(2):191-5, 2013. (IF: 1.318).
  • Murdaca G., Spanò F., Cagnati P., Puppo F. Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. Redox Rep 18(3):95-9, 2013. (IF: 1.732).
  • Fenoglio D., Traverso P., Parodi A., Tomasello L., Negrini S., Kalli F., Battaglia F., Ferrera F., Sciallero S., Murdaca G., Setti M., Sobrero A., Boccardo F., Cittadini G., Puppo F., Criscuolo D., Carmignani G., Indiveri F., Filaci G. A Multi-Peptide, Dual-Adjuvant Telomerase Vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunol Immunother 62(6):1041-52, 2013. (IF: 3.701).
  • Murdaca G., Spanò F., Puppo F. Selective TNF alpha inhibitor-induced injection site reactions. Expert Opin Drug Saf 12(2):187-93, 2013. (IF: 3.015).
  • Murdaca G., Spanò F., Miglino M., Puppo F. Effects of TNF-alpha inhibitors upon the mechanisms of action of VEGF. Immunotherapy 5(2):113-5, 2013. (IF: 2.393).
  • Murdaca G., Colombo BM., Cagnati P., Gulli R., Spanò F., Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 224:309-17,2012. (IF: 4.086).
  • Ansaldi F., Valle L., de Florentiis D., Parodi V., Murdaca G., Bruzzone BM., Durando P., Setti M., Icardi G. Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother 8(8): 1048-52, 2012. (IF: 2.042).
  • Murdaca G., Colombo BM., Contini P., Puppo F. Determination of lymphotoxin-α levels in patients with psoriatic arthritis undergoing etanercept treatment. J Interferon Cytokine Res 32(6):277-9, 2012. (IF: 3.063).
  • Murdaca G., Colombo BM., Cagnati P., Gulli R., Spanò F., Puppo F. Update upon efficacy and safety of TNF-α inhibitors. Expert Opin Drug Saf 11(1):1-5, 2012. (IF: 2.645).
  • Murdaca G., Cagnati P., Gulli R., Spanò F., Puppo F., Campisi C., Boccardo F. Current views on diagnostic approach and treatment of lymphedema. Am J Med 125(2):134-40, 2012. (IF: 5.115).
  • Campisi C, Witte MH, Fulcheri E, Campisi C, Bellini C, Villa G, Campisi C, Santi PL, Parodi A, Murdaca G, Puppo F, Boccardo F. General surgery, translational lymphology and lymphatic surgery. Int Angiol 30(6):504-21, 2011. (IF: 0.993).
  • Murdaca G., Colombo BM., Puppo F. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events. Autoimmun Rev 11(1):56-60, 2011. (IF: 6.556).
  • Murdaca G., Contini P., Setti S., Cagnati P., Spanò F., Lantieri F., Puppo F. Soluble HLA-G serum levels in patients with the Acquired Immunodeficiency Syndrome affected by different AIDS-defining conditions before and after anti-retroviral treatment. Human Immunology 72:712-6, 2011. (IF: 2.550).
  • Murdaca G., Colombo BM., Puppo F. Adalimumab in the treatment of immune-mediated diseases: an update on old and recent indications. Drugs Today (Barc) 47(1):277-88, 2011. (IF: 1.588).
  • Murdaca G., Colombo BM., Puppo F. The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med 6(6):487-95,2011. (IF: 2.139).
  • Boccardo F., Campisi C., Murdaca G., Benatti E., Boccardo C., Puppo F., Campisi C. Prevention of lymphatic injuries in surgery. Microsurgery 30(4):261-5, 2010. (IF: 1.244).
  • Cagnati P., Colombo BM., Gulli R., Russo R., Boccardo F., Campisi C., Puppo F., Murdaca G. Nocturia: an uncommon presentation of lower limb lymphedema. Am J Med 123(3):e3-4, 2010. (IF: 5.105).
  • di Poggio MB., Murdaca G., Puppo F., Primavera A. Antiphospholipid syndrome and reversible posterior leukoencephalophaty syndrome. Semin Arthritis Rheum 40(3):e9-10, 2010. (IF: 4.379).
  • Murdaca G., Colombo BM., Barabino G., Caiti M., Cagnati P., Puppo F. Anti-tumour necrosis factor-a treatment with infliximab for disseminated granuloma annulare. Am J Clin Dermatol 11(6):437-9, 2010. (IF: 1.554).
  • Murdaca G., Contini P., Setti M., Cagnati P., Lantieri F., Indiveri F., Puppo F. Behavior of non-classical soluble HLA class G antigens in Human Immunodeficiency Virus 1-infected patients before and after HAART: comparison with classical soluble HLA -A, -B, -C antigens and potential role in immune-reconstitution. Clin Immunol 133:238-44, 2009. (IF: 3.606).
  • Murdaca G., Colombo BM, Puppo F. Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events.. Int J Immunopathol Pharmacol 22(3):557-65, 2009. (IF: 2.793).
  • Ciprandi G., Fenoglio D., De Amici M., Marseglia G., Murdaca G., Di Gioacchino M. Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch. European Journal of Inflammation 7(1):49-51, 2009. (IF: 2).
  • Ciprandi G., De Amici M., Murdaca G., Fenoglio D., Ricciardolo F., Marseglia G., Tosca M. Serum interleukin-17 levels are related to clinical severity in allergic rhinitis. Allergy 64(9):1375-8, 2009 . (IF: 6.2).
  • Ciprandi G., De Amici M., Tosca M., Negrini S., Murdaca G., Marseglia GL. Two year sublingual immunotherapy affects serum leptin. Int Immunopharmacol 9(10):1244-6, 2009. (IF: 2).
  • Ciprandi G., Contini P., Murdaca G., DeAmici M., Gallina AM., Puppo F. Soluble serum HLA-G and HLA-A,-B,-C molecules in patients with seasonal allergic rhinitis exposed to pollens. Int Immunopharmacol 9(9):1058-62, 2009. (IF: 2).
  • Fenoglio D., Poggi A., Castellani S., Battaglia F., Ferrera A., Setti M., Murdaca G., Zocchi MR. Vd1 T lymphocytes producing IFN-g and IL-17 are expanded in HIV-1 infected patients and respond to Candida albicans. Blood 113(26):6611-8, 2009. (IF:10.896).
  • Boccardo FM., Ansaldi F., Bellini C., Accogli S., Taddei G., Murdaca G., Campisi CC., Villa G., Icardi G., Durando P., Puppo F., Campisi C. Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer. Lymphology 42(1):1-9, 2009. (IF: 0.778).
  • Ciprandi G., Contini P., Murdaca G., Gallina A.M., Puppo F. Soluble HLA-G molecule in patients with perennial allergic rhinitis. Int Arch Allergy Immunol 150(3):278-281, 2009. (IF:2.2).
  • Bezante GP., Briatore L., Rollando D., Maggi D., Setti M., Ghio M., Agosti S., Murdaca G., Balbi M., Barsotti A., Cordera R. Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage. Nutr Metab Cardiovasc Dis 19(4):277-82, 2009. (IF: 3.174).
  • Ciprandi G., Contini P., Pistorio A., Murdaca G., Puppo F. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Int Immunopharmacol 9:253–7, 2009. (IF: 2).
  • Ciprandi G., De Amici M., Murdaca G., Filaci G., Fenoglio D., Marseglia GL. Adipokines and sublingual immunotherapy: preliminary report. Hum Immunol 70(1):73-8, 2009. (IF: 3).
  • Colombo BM., Cacciapaglia F., Puntoni M., Murdaca G., Rossi E., Rodriguez G., Nobili F., Pisciotta L., Bertolini S., Moccetti T., Dentali F., Steidl L., Ciprandi G., Afeltra A., Indiveri F., Puppo F. Traditional and nontraditional risk factors in accelerated atherosclerosis in Systemic Lupus Erythematosus: Role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev 8(4):309-15, 2009. (IF: 3.862).
  • Ciprandi G., Murdaca G., Colombo BM., De Amici M., Marseglia GL. Serum vascular endothelial growth factor in allergic rhinitis and systemic lupus erythematosus. Hum Immunol. 69(8):510-2, 2008. (IF: 3).
  • Murdaca G., Cagnati P., Gulli R., Caiti M., Boccardo F., Campisi C., Puppo F. Recurrent intestinal perforation associated with thrombosis of inferior vena cava: uncommon presentation of antiphospholipid syndrome. J Rheumatol. 35(11):2291-2, 2008. (IF: 3,151).
  • Ciprandi G., Colombo BM., Contini P., Cagnati P., Pistorio A. , Puppo F., Murdaca G. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Allergy 63(10):1335-8, 2008. (IF: 6.2).
  • Ciprandi G., De Amici M., Murdaca G., Colombo BM., Quaglini S., Marseglia G., Di Gioacchino M. Serum IL-4 as a marker of immunological response to sublingual immunotherapy. J Biol Regul Homeost Agents 22(2):117-23, 2008.(IF:2.9).
  • Ciprandi G., Colombo BM., Murdaca G., De Amici M. Serum vascular endothelial growth factor and sublingual immunotherapy. Allergy 63(7):945-6, 2008. (IF: 6.2).
  • Ciprandi G., Murdaca G., Marseglia G., Colombo BM., Quaglini S., De Amici M. Serum adiponectin levels in patients with pollen-induced allergic rhinitis. Int Immunopharmacol 8(6):945-9, 2008. (IF: 2).
  • Colombo BM., Murdaca G., Ciprandi G., Sormani MP. Body mass index in Th1 and Th2 diseases. Immunol Lett 117(1):119-20, 2008. (IF: 2.8).
  • Giovannetti A., Pierdominici M., Di Iorio A., Cianci R., Murdaca G., Puppo F., Pandolfi F., Paganelli R. Apoptosis in the Homeostasis of the Immune System and in Human Immune Mediated Diseases. Curr Pharm Des 14(3):253-68, 2008. (IF: 4.868).
  • Murdaca G., Contini P., Setti M., Cagnati P., Villa R., Lantieri F., Indiveri F., Puppo F. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome. Human Immunology 68: 894-900, 2007. (IF: 2.901).
  • Murdaca G., Colombo BM., Sprecacenere B., Caiti M., Massa G., Picciotto A., Ceppa P., Puppo F. Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome. Eur J Gastroenterol Hepatol 19(10): 910-912 , 2007. (IF: 1.830).
  • Colombo BM., Murdaca G., Caiti M., Rodriguez G., Grassia L., Rossi E., Indiveri F, Puppo F. Intima-media thickness. A marker of accelerated atherosclerosis in women with Systemic Lupus Erythematosus. Ann N Y Acad Sci 1108: 121-126, 2007. (IF: 1.731).
  • Murdaca G., Colombo BM., Caiti M., Cagnati P., Massa G., Puppo F. Remission of Brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case report. Int J Cardiol 117(1): e35-e36, 2007. (IF: 2.878).
  • Colombo BM., Murdaca G., Sprecacenere B., Rodriguez G., Rossi E., Puppo F. Accelerated atherosclerosis in patients with Systemic Lupus Erythematosus. It J Allergy Clin Immunol 16: 105-108, 2006.
  • Murdaca G., Costantini S., Villa R., Setti M., Puppo F., Indiveri F. A case of transposition of the great arteries in a female infant of a HIV-1 infected woman. Potential teratogenic effect of antiretroviral drugs. Intern Emerg Med 1 (1): 86-88, 2006.
  • Puppo F., Murdaca G., Ghio M., Indiveri F. Emerging biologic drugs for the treatment of rheumatoid arthritis. Autoimmun Rev 4: 537-541, 2005. (IF: 3.862).
  • McDermott JL., Martini I., Ferrari D., Bertolotti F., Giacomazzi C., Murdaca G., Puppo F., Indiveri F., Varnier OE. Decay of Human Immunodeficiency Virus Type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia. J Clin Microbiol 43: 5272-5274, 2005. (IF: 3.913).
  • Poggi A., Contini P., Catellani S., Setti M., Murdaca G., Zocchi MR. Regulation of gammadelta T cell survival by soluble HLA-I: Involvement of CD8 and activating killer Ig-like receptors. Eur J Immunol 35: 2670-2678, 2005.(IF:4.832).
  • Filaci G., Rizzi M., Setti M., Fenoglio D., Fravega M., Basso M., Ansaldo G., Ceppa P., Borgonovo G., Murdaca G., Ferrera F., Picciotto A., Fiocca R., Torre G., Indiveri F. Non-Antigen-Specific CD8+ T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. Ann N Y Acad Sci 1050: 115-123, 2005. (IF: 1.731).
  • Fogli M., Costa P., Murdaca G., Setti M., Mingari MC., Moretta L., Moretta A., De Maria A. Significant NK cell activation is associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients. Eur J Immunol 34(8): 2313-2321, 2004.(IF:4.832).
  • Poggi A., Carosio R., Fenoglio D., Brenci S., Murdaca G., Setti M., Indiveri F., Scabini S., Ferrero E., Zocchi MR. Migration of Vd1and Vd2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1 infected patients: competition by HIV-1 TAT. Blood 103(6): 2205-2213, 2004. (Pubblicato online il 20/11/2003). (IF: 9.782).
  • Murdaca G., Setti M., Brenci S., Fenoglio D., Lantieri P, Indiveri F., Puppo F. Modifications of immunological and neuro-endocrine parameters induced by antiorthostatic bed-rest in human healthy volunteers. Minerva Med 94(6): 363-378, 2003.
  • Murdaca G., Setti M., Cittadini G., Gentile G., Menin A., Fiocca R., Gobbi M., Puppo F., Indiveri F. Sindrome mediastinica: presentazione clinica di linfoma. Descrizione di un caso di linfoma di Hodgkin e di un caso di linfoma non Hodgkin con analoga presentazione. Ann Ital Med Int 18(3): 170-181, 2003.
  • De Maria A., Fogli M., Costa P., Murdaca G., Puppo F., Mavilio D., Moretta A., Moretta L. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol 33(9):2410-2418 , 2003.(IF:4.832).
  • Costa P., Rusconi S., Fogli M., Mavilio D., Murdaca G., Puppo F., Mingari M.C., Galli M., Moretta L., De Maria A. Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients. AIDS 17(2): 257-260, 2003.(IF: 6.881).
  • Indiveri F., Murdaca G. Immunogenicity of erythropoietin and other growth factors. Rev Clin Exp Hematol, Supplemento 1: 7-11, 2002.
  • Murdaca G., Campelli A., Setti M., Indiveri F., Puppo F. Complete remission of AIDS/KS after treatment with a combination of two NRTIs and one NNRTI. AIDS 16(2): 304-305, 2002. (Lettera) (IF: 6.881).
  • Basso M., Filaci G., Cutolo M., Murdaca G., Derchi L., Gianrossi R., Ropolo F., Zentilin P., Sulli A., Puppo F., Indiveri F. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Ann Ital Med Int 16(4): 233-239, 2001.
  • Filaci G., Cutolo M., Basso M., Murdaca G., Derchi L., Gianrossi R., Ropolo F., Zentilin P., Sulli A., Puppo F., Indiveri F. Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology 40(12): 1431-1432, 2001.(Lettera) (IF: 3.062).
  • Costa P., Rusconi S., Mavilio D., Fogli M., Murdaca G., Pende D., Mingari M.C., Galli M., Moretta L. De Maria A. Differential disappearance of inhibitory natural killer cell receptors during HAART and possibile impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. AIDS 15(8): 965-974, 2001.(IF: 6.881).
  • Murdaca G., Setti M., Campelli A., Ghio M., Puppo F., Indiveri F. Utilizzo dell’Amfotericina B liposomiale nel trattamento della fase acuta e nella profilassi secondaria della leishmaniosi viscerale in un paziente HIV positivo. Infez Med 8(4): 241-244, 2000.
  • Borrelli P., Imperato A., Murdaca G., Scudeletti M. Liposomal Amphotericin B as first line and secondary prophylactic treatment for Visceral Leishmaniasis in a patient infected with HIV. .Ann Ital Med Int 15(2): 169-171, 2000.
  • Filaci G., Cutolo M., Scudeletti M., Castagneto C., Derchi L., Gianrossi R., Ropolo F., Zentilin P., Sulli A., Murdaca G., Ghio M., Indiveri F., Puppo F. Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. Rheumatology 38(10):992-996, 1999.(IF: 3.062).
  • Parodi M.N., Castagneto C., Filaci G., Murdaca G., Puppo F., Indiveri F., Scudeletti M. Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. Br J Rheumatol. 36(2):244-250, 1997.(IF:3.062).Ferri C, Giuggioli D, Raimondo V, Fallahi P, Antonelli A; COVID-19 & ASD Italian Study Group. COVID-19 in Italian patients with rheumatic autoimmune systemic diseases. Ann Rheum Dis. 2023;82(9): e211. (IF: 16.102).Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2021;19(1):442. (IF: 4.197).
  • Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med. 2020;18(1):405. (IF: 4.197).
  • Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airò P, Valentini G, Matucci Cerinic M, Distler O, Cozzi F, Carreira P, Allanore Y, Müller-Ladner U, Ananieva LP, Balbir-Gurman A, Distler JHW, Czirják L, Li M, Henes J, Jimenez SA, Smith V, Damjanov N, Denton CP, DelGaldo F, Saketkoo LA, Walker UA; EUSTAR co-authors. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study. Rheumatology (Oxford). 2020;59(7):1684-94. (IF: 5.149).
  • Fernández-Codina A, Walker KM, Pope JE; Scleroderma Algorithm Group. Treatment Algorithms for Systemic Sclerosis According to Experts. Arthritis Rheumatol. 2018;70(11):1820-1828.
  • Murray DD, Suzuki K, Law M, Trebicka J, Neuhaus J, Wentworth D, Johnson M, Vjecha MJ, Kelleher AD, Emery S; INSIGHT ESPRIT and SMART Study Groups. Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study. PLoS One. 2015;10(10):e0139981. (IF: 2.766).
  • Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015;12(3):e1001809. (IF: 14.000).
  • Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc 2014;3(3):e000844.
  • INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. Interleukin-2 therapy in patients with HIV infection. N Engl J Med 361(16):1548-59, 2009. (IF: 50.017).
  • Saracino A., Gianotti N., Marangi M., Cibelli DC., Galli A., Punzi G., Monno L., Lazzarin A., Angarano G.; Mutations, Salvage Study Group. Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART. J Med Virol 80(10):1695-706, 2008. (IF: 2.831).
  • Palmisano L., Giuliano M., Bucciardini R., Fragola V., Andreotti M., Galluzzo CM., Pirillo MF., Weimer LE., Arcieri R., Germinario EA., Amici R., Mancini MG., d’Arminio Monforte A., Castelli F., Caramello P., Vella S. and the Italian ISS-PART Clinical Centers. Determinants of virologic and immunologic outcomes in chronically HIV-infected subjects undergoing repeated treatment interruptions: the Istituto Superiore di Sanità-Pulsed Antiretroviral Therapy (ISS-PART) Study. J Acquir Immune Defic Syndr 46: 39-47, 2007. (IF: 4.412).
  • Puro V., De Carli G., Ippolito G. and the Italian registry of antiretroviral post-exposure prophylaxis. Postexposure HIV prophylaxis regimen. Clin Infect Dis 40(1):205-206, 2005. (IF:5.393).
  • Puro V., Soldani F., Cicalini S., De Carli G., Ippolito G. Hepatic safety and postexposure prophylaxis. Clin Infect Dis 39(7): 1083-1084, 2004. (IF:5.393).
  • Puro V., Soldani F., De Carli G., Lazarevic Z., Mattioli F., Ippolito G., on behalf of the Italian Registry of Antiretroviral Post-Exposure Prophylaxis. Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis. AIDS 17(13):1988-1990, 2003.(IF: 6.881).
  • The Genoese Group for the Study of Systemic Sclerosis. Clinical evaluation of systemic sclerosis : a comprehensive panel of diagnostic tests to asses skin, microvascular and visceral involvement. Ann Ital Med Int 14(2):79-85, 1999.Cagnati P., Puppo F., Fazzuoli L., Murdaca G. Multiparametric endocrine evaluation of healthy subjects undergoing prolonged head down tilt bed rest anti-gravitary posture. Journal of space exploration 2(1), 2013.
  • Murdaca G., Puppo F. Tumor Necrosis Factor (TNF)-α Gene +489 Polymorphisms: Association with Psoriatic Arthritis. J Biol Res LXXXVI (1):38-41, 2013.
  • Boccardo F., Murdaca G., Cagnati P., Gulli R., Caiti M., Dessalvi S., Puppo F., Campisi C. Differential diagnosis in recurrent intestinal perforation: chronic inflammatory disease with intestinal lymphedema or antiphospholipid syndrome? The European Journal of Lymphology 23(65):20-22, 2012.
  • Murdaca G., Cagnati P., Puppo F. Soluble HLA-G serum levels in patients with the Acquired Immunodeficiency Syndrome affected by different AIDS-defining conditions before and after anti-retroviral treatment. J Biol Res LXXXIV(1):144-147, 2011.
  • Murdaca G., Cagnati P., Puppo F. Serum Levels of Classical HLA Class I Antigen in HIV-Infected Patients During Antiretroviral Therapy. Correlation with the Clinical Outcome. J Biol Res LXXXII (1): 88-93, 2009.
  • Murdaca G., Barabino G., Puppo F. Efficacia del trattamento con anti-TNF-alfa in una paziente affetta da granuloma annulare generalizzato. Immune Mediated Inflammatory diseases. Case reports. Volume VI, 2007.
  • Cagnati P., Murdaca G., Colombo B.M., Puppo F. Modifications of Neuro-Endocrine Parameters Induced by Antiorthostatic Bed-Rest in Human Healthy Volunteers. Exp Biol Rep .1: 1-11, 2007.
  • Coautore di: Puro V, De Carli G, Signorini L, Pan A., Del Borgo C., Fantoni M., Orchi N., Calcagno G., Calzetti C., Franco A., Cassola G., Niero F., Raineri G., Salassa B., Vivarelli A., Irato L., Ippolito G. Registro italiano delle profilassi con antiretrovirali dopo esposizione occupazionale, sessuale o parenterale ad HIV- Aggiornamento 2003. Giornale Italiano di Malattie Infettive 10(Suppl 1): S154-S155, 2004.
  • Varnier OE., McDermott JL., Giri AA., Bertolotti F., Martini I., Levreri I., Giacomini M., Mora R., Mora F., Campelli A., Murdaca G., Puppo F., Indiveri F. Virological markers in HIV-1 infected patients. Minerva Ginecologica 54(Suppl 1 al N. 6): 9-13, 2002.
  • Icardi G., Murdaca G., Marasso P., Gota F., Massone L., Bacilieri S., Valle L., Tinteri C. Valutazione mediante sequenziamento virale della prevalenza di mutazioni associate a resistenza ai farmaci antiretrovirali in pazienti HIV+ naive. Sanità e Sicurezza, supplemento speciale riferito al Tomo n. 1: 253-256 ,ottobre 2002.
  • Murdaca G., Indiveri F., Puppo F. Prospettive immunoterapeutiche nella infezione da HIV. CIC Edizioni Internazionali, settembre 2002.
    No content available to display!!!